Changfu Cheng obtained his Master’s degree in Organic Synthesis at Southern Illinois University in 1994 and completed his PhD training in mass spectrometry at Washington University in St. Louis in 1998. He has worked in the fields of drug metabolism and bioanalysis for more than 15 years. He is currently the Director of  bioanalytics  at  Concert  Pharmaceuticals,  in  charge  of  the  company’s  analytical  laboratory  that  supports  medicinal  chemistry,  pharmacokinetics,  formulation,  stability, structural elucidation and metabolite identification. Because of the company’s unique platform, his work involves many therapeutic areas such as fibrosis, oncology, nephrology, endocrinology and ophthalmology Changfu Cheng obtained his Master’s degree in Organic Synthesis at Southern Illinois University in 1994 and completed his PhD training in mass spectrometry at Washington University in St. Louis in 1998. He has worked in the fields of drug metabolism and bioanalysis for more than 15 years. He is currently the Director of  bioanalytics  at  Concert  Pharmaceuticals,  in  charge  of  the  company’s  analytical  laboratory  that  supports  medicinal  chemistry,  pharmacokinetics,  formulation,  stability, structural elucidation and metabolite identification. Because of the company’s unique platform, his work involves many therapeutic areas such as fibrosis, oncology, nephrology, endocrinology and ophthalmology

Drug Metabolism, Bioanalysis, and Toxicology